02646naa a2200277 a 450000100080000000500110000800800410001902400460006010000190010624501620012526000090028752018360029665000170213265000150214965000110216465000140217565000140218965000180220365000280222170000170224970000180226670000200228470000170230470000180232177300290233921019072018-12-18       2018    bl uuuu     u00u1 u    #d7 adoi.org/10.1371/journal.pone.01915962DOI1 aCSORDAS, B. G.  aMolecular characterization of the recombinant protein RmLTI-BmCG-LTBbProtective immunity against Rhipicephalus (Boophilus) microplus.h[electronic resource]  c2018  aThe bovine tick Rhipicephalus (Boophilus) microplus is found in several tropical and subtropical regions of the world. This parasite transmits pathogens that cause disease, such as babesiosis ( Babesia bovis and B . bigemina ) and anaplasmosis (Anaplasma marginale). Tick infestations cause enormous livestock losses, and controlling tick infestations and the transmission of tick-borne diseases remains a challenge for the livestock industry. Because the currently available commercial vaccines offer only partial protection against R. (B.) microplus, there is a need for more efficient vaccines. Several recombinant antigens have been evaluated using different immunization strategies, and they show great promise. This work describes the construction and immunological characterization of a multi-antigen chimera composed of two R. (B.) microplus antigens (RmLTI and BmCG) and one Escherichia coli antigen (B subunit, LTB). The immunogenic regions of each antigen were selected and combined to encode a single polypeptide. The gene was cloned and expressed in E . coli . For all of the experiments, two groups (treated and control) of four Angus heifers (3?6 months old) were used. The inoculation was performed via intramuscular injection with 200 μ g of purified recombinant chimeric protein and adjuvated. The chimeric protein was recognized by specific antibodies against each subunit and by sera from cattle inoculated with the chimera. Immuni-zation of RmLTI-BmCG- LTB cattle reduced the number of adult female ticks by 6.29% and vaccination of cattle with the chimeric antigen provided 55.6% efficacy against R . (B.) microplus infestation. The results of this study indicate that the novel chimeric protein is a potential candidate for the future development of a more effective vaccine against R . (B.) microplus .  aAnaplasmosis  aBabesiosis  aCattle  aParasites  aPathogens  aRhipicephalus  aRhipicephalus microplus1 aCUNHA, R. C.1 aGARCIA, M. V.1 aSILBA, S. da S.1 aLEITE, F. L.1 aANDREOTTI, R.  tPLOS ONE, February, 2018